Reuters Health Report: FDA wants to shorten new drug monopolies to cut costs

FDA wants to shorten new drug monopolies to cut costs

CHICAGO (Reuters) - In an effort to increase competition and bring down prescription drug prices, FDA Commissioner Dr. Scott Gottlieb wants to speed approval times for rivals to promising new first-to-market medicines.

Mixed results for Bristol/Nektar combination in cancer trial

Chicago (Reuters) - Mixed results over the weekend from closely watched studies combining Bristol-Myers Squibb Co's cancer immunotherapy with Nektar Therapeutics experimental drug NKTR-214, led at least one Wall Street analyst to reassess expectations.

Many women with early-stage breast cancer can skip chemotherapy: study

CHICAGO (Reuters) - Some 70 percent of women with early-stage breast cancer and an intermediate risk of cancer recurrence can safely skip chemotherapy after their tumors have been removed, U.S. researchers said on Sunday.

Merck's Keytruda extends lung cancer survival in two trials

CHICAGO (Reuters) - Merck & Co's immunotherapy Keytruda improved survival as a stand-alone treatment for newly-diagnosed lung cancer patients and with chemotherapy for hard-to-treat squamous cell lung cancer, new data released on Sunday showed, further cementing the company's lead in the most lucrative oncology market.

FDA chief outlines new ways to speed cancer drug approvals

CHICAGO (Reuters) - The U.S. Food and Drug Administration is taking steps to streamline the approval process for cancer drugs, reviewing clinical trial data up front to make sure applications companies submit are complete.

Roche drugs show limited benefit in lung, breast cancer trials

CHICAGO (Reuters) - In a disappointment for Roche Holding AG , two of its oncology drugs provided only modest protection from disease progression in lung cancer and breast cancer, according to data from separate clinical trials presented on Saturday.

Grail blood test shows promise in early detection of lung cancer

CHICAGO (Reuters) - An experimental blood screening test from Grail Inc showed early promise in detecting early-stage lung cancers based on free-floating DNA released by tumors, according to preliminary results released on Saturday.

Loxo Oncology posts improved results for newest cancer drug

CHICAGO (Reuters) - An experimental cancer drug from Loxo Oncology performed even better in patients with a rare mutation of the RET gene than previously reported, according to updated results from an early stage clinical trial presented on Saturday.

Gene sequencing study finds new cancers linked with Lynch syndrome

CHICAGO (Reuters) - Lynch syndrome, a rare hereditary disease typically associated with an increased risk of colorectal and endometrial cancers, appears to be linked with several additional types of cancer than previously thought, U.S. researchers said on Saturday.

Coal lobby fights black-lung tax as disease rates surge

PRINCETON, West Virginia (Reuters) - As a young man, Barry Shrewsbury dug coal in the West Virginia mines and spent his time off hunting and fishing in the rolling hills.

Related Videos

Gravity energy generator could revolutionise renewables

Slovene beekeepers hope to have a stinging impact on bee preservation

You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here